Local Institution

Langres 52206

0 studies enrolling now · 4 studies all time

What they study most

Acute Coronary Syndrome, Atrial Fibrillation, Congestive Heart Failure, Venous Thrombosis

Studies at this site

• A Phase III Study of Apixaban in Patients With Atrial Fibrillation — Completed
• Phase III Acute Coronary Syndrome — Stopped early
• Irbesartan in Heart Failure With Preserved Systolic Function (I-Preserve) — Completed
• Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism — Completed